Lynx Investment Advisory Abb Vie Inc. Transaction History
Lynx Investment Advisory
- $135 Billion
- Q2 2024
A detailed history of Lynx Investment Advisory transactions in Abb Vie Inc. stock. As of the latest transaction made, Lynx Investment Advisory holds 1,610 shares of ABBV stock, worth $311,551. This represents 0.2% of its overall portfolio holdings.
Number of Shares
1,610Holding current value
$311,551% of portfolio
0.2%Shares
1 transactions
Others Institutions Holding ABBV
# of Institutions
3,693Shares Held
1.27BCall Options Held
13MPut Options Held
9.79M-
Vanguard Group Inc Valley Forge, PA171MShares$33 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.1 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.4 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.47 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $342B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...